The U.S. Federal Trade Commission gained the power to pursue a more aggressive antitrust agenda after the agency added a fifth commissioner, giving Democrats a majority for the first time in more than a year.
U.S. Federal Trade Commission Chairman Jon Leibowitz took time away from a Southern California technology conference to dine with a senior executive at Google Inc., the subject of an intensifying government antitrust probe.
The U.S. Federal Trade Commission said drug-company deals that delayed the introduction of cheaper generic medicines rose 63 percent last year as the agency presses Congress and the courts to limit the settlements.
The U.S. is probing the possibility of anticompetitive practices in the e-book industry, Sharis Pozen, the acting chief of the U.S. Justice Department’s antitrust division told a House committee in Washington yesterday.
The U.S. Supreme Court agreed to take up a multibillion-dollar fight between the drug industry and federal antitrust enforcers, a case that may determine how quickly low-price generic medicines reach the market.
A multibillion-dollar fight between the drug industry and antitrust enforcers is poised to get U.S. Supreme Court review in a case that may determine how quickly low-price generic medicines reach the market.